tradingkey.logo

Biomerica Inc

BMRA

2.880USD

-0.050-1.71%
Close 09/19, 16:00ETQuotes delayed by 15 min
7.33MMarket Cap
LossP/E TTM

Biomerica Inc

2.880

-0.050-1.71%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
142 / 207
Overall Ranking
405 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.31M.
Overvalued
The company’s latest PE is -10.72, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 405.55K shares, decreasing 31.74% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 21.13K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.18.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.71, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 749.00K, representing a year-over-year decrease of 32.89%, while its net profit experienced a year-over-year decrease of 8.66%.

Score

Industry at a Glance

Previous score
6.71
Change
0

Financials

8.95

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

9.33

Operational Efficiency

3.66

Growth Potential

4.43

Shareholder Returns

7.18

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -10.91, which is 15.77% below the recent high of -12.63 and -101.15% above the recent low of -21.94.

Score

Industry at a Glance

Previous score
2.80
Change
1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 142/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.01, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 3.51 and the support level at 2.44, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.01
Change
-0.07

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.008
Neutral
RSI(14)
41.693
Neutral
STOCH(KDJ)(9,3,3)
52.720
Sell
ATR(14)
0.210
High Vlolatility
CCI(14)
-37.450
Neutral
Williams %R
49.275
Neutral
TRIX(12,20)
-0.429
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.944
Sell
MA10
2.940
Sell
MA20
3.022
Sell
MA50
3.193
Sell
MA100
3.270
Sell
MA200
3.763
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 15.93%, representing a quarter-over-quarter increase of 1.94%. The largest institutional shareholder is The Vanguard, holding a total of 21.13K shares, representing 0.75% of shares outstanding, with 25.31% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Irani (Zackary S)
158.82K
+24.50%
Barbieri (Allen)
23.54K
+140.42%
Geode Capital Management, L.L.C.
19.57K
+32.13%
The Vanguard Group, Inc.
Star Investors
21.13K
--
Potomac Capital Management Inc.
20.96K
-2.22%
Emerson (Jane)
19.50K
+119.72%
Lu (Gary)
19.38K
--
BlackRock Institutional Trust Company, N.A.
18.64K
--
Coste (Catherine)
16.10K
+194.10%
Moatazedi (David)
10.63K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.11, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.35. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.11
Change
0
Beta vs S&P 500 index
0.35
VaR
+8.14%
240-Day Maximum Drawdown
+66.63%
240-Day Volatility
+185.17%
Return
Best Daily Return
60 days
+17.28%
120 days
+17.28%
5 years
+101.71%
Worst Daily Return
60 days
-9.69%
120 days
-26.29%
5 years
-28.06%
Sharpe Ratio
60 days
+0.18
120 days
-0.96
5 years
-0.14
Risk Assessment
Maximum Drawdown
240 days
+66.63%
3 years
+93.62%
5 years
+96.67%
Return-to-Drawdown Ratio
240 days
+0.09
3 years
-0.32
5 years
-0.20
Skewness
240 days
+5.77
3 years
+4.91
5 years
+4.60
Volatility
Realised Volatility
240 days
+185.17%
5 years
+126.15%
Standardised True Range
240 days
+14.37%
5 years
+49.63%
Downside Risk-Adjusted Return
120 days
-136.94%
240 days
-136.94%
Maximum Daily Upside Volatility
60 days
+123.18%
Maximum Daily Downside Volatility
60 days
+69.16%
Liquidity
Average Turnover Rate
60 days
+4.00%
120 days
+2.30%
5 years
--
Turnover Deviation
20 days
+18.17%
60 days
-57.15%
120 days
-75.37%

Peer Comparison

Healthcare Equipment & Supplies
Biomerica Inc
Biomerica Inc
BMRA
4.08 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI